GLP-1 Drugs For Weight Loss Aren’t Cost-Saving Yet
Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...
Could Trump Make A Big Weight Loss Drug Deal?
Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...
West Virginia patients are left in limbo over changing insurance coverage of obesity medications
Lory Osborn says the Wegovy she was prescribed 15 months ago did more than help her lose 75 pounds — over a quarter of her ...
The Bulwark4h
Ozempic and Your Community
How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...
Governing8h
Should Medicaid Pay for Ozempic and Other Weight-Loss Drugs?
With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.
Zepbound will dominate obesity market following SURMOUNT-5 results, says analyst
According to key opinion leaders, positive SURMOUNT-5 results, alongside Lilly’s business strategy, means Zepbound is set to ...
朝日新聞社3d
Novo to launch Wegovy in Asia with February Japan roll-out
which is in the process of convincing some governments to pay for Wegovy for the most overweight. The monthly cost for patients will be 7,504 Japanese yen ($50.15) for a 0.25-milligram starter ...
Yahoo4d
West Virginia patients are left in limbo over changing insurance coverage of obesity medications
(AP) — Lory Osborn says the Wegovy she was prescribed 15 ... adopted similar stances for the drugs, which can cost patients more than $1,000 monthly out-of-pocket. In 2024, Blue Cross Blue ...